WFS1 and diabetes mellitus: To assess whether dulaglutide could indeed reverse impaired glucose tolerance or diabetes (Fig. 2a), we treated 7- and 20-week-old Wfs1 KO mice for 4–12 weeks (Fig. 2b–e).